Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Tremble; General debility; This is a spontaneous report received from a non-contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is DE-PEI-202100055350. A 94-year-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 30Mar2021 (Lot number ER7812) as 0.3 ml single dose for COVID-19 immunisation. The patient''s medical history included epilepsy (Last seizure 2010) and diabetes. The patient''s concomitant medications were not reported. The patient previously received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 09Mar2021 as 0.3 ml single dose for COVID-19 immunisation. On 07Apr2021, the patient experienced fatal events general debility, tremble. The patient died on 30Apr2021. Cause of death also reported as unknown cause of death. Regulatory Authority assessed the relatedness of drug to reactions/events as D. Unclassifiable. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: general debility; tremble
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166